Paul Barton Rodgers
Directeur Général chez Ithaka Life Sciences Ltd.
Profil
Paul Barton Rodgers founded Ampika Ltd.
in 2003, where he worked as Non-Executive Director, CYP Design Ltd.
in 2012, where he worked as Non-Executive Director, and Mironid Ltd.
in 2014, where he is working as Executive Chairman from 2014.
Dr. Rodgers also founded Ithaka Life Sciences Ltd., where he worked as Managing Director.
Dr. Rodgers also currently works at ProteinLogic Ltd., as Chairman.
Dr. Rodgers also formerly worked at Psynova Neurotech Ltd., as Director.
Postes actifs de Paul Barton Rodgers
| Sociétés | Poste | Début |
|---|---|---|
Ithaka Life Sciences Ltd.
 Ithaka Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services Ithaka Life Sciences Ltd. provides advisory, guidance, and support for the life science industry. The British company was founded by Paul Barton Rodgers, who has been the CEO since incorporation. | Directeur Général | - |
ProteinLogic Ltd.
 ProteinLogic Ltd. Packaged SoftwareTechnology Services ProteinLogic Ltd. has developed a diagnostic technology platform called immiprint®, which detects non-obvious diagnostic patterns in soluble immune proteins in the blood and other body fluids through machine learning. ProteinLogic is based in Cambridge, UK. These patterns form unique signatures of disease presence, stage, and potential response to treatment. The immiprint® technology has been clinically validated with the development of a signature in blood for the ruling out of active tuberculosis (TB), meeting the stringent criteria of the WHO for such a diagnostic test. The British company expects to create considerable additional value through the validation of other immiprint® signatures in its early stage development pipeline, with a focus on infectious, autoimmune, and inflammatory diseases. | Président | - |
Mironid Ltd.
 Mironid Ltd. Pharmaceuticals: MajorHealth Technology Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom. | Fondateur | 01/01/2014 |
Anciens postes connus de Paul Barton Rodgers
| Sociétés | Poste | Fin |
|---|---|---|
Ampika Ltd.
 Ampika Ltd. Drugstore ChainsRetail Trade Ampika Ltd. discovers and develops drugs. It develops consumer products and prescription drugs from plant-based compounds. Its products includes cardiovascular protection, anti-infectives, diabetes, oncology, dermatological conditions and neurological. The company was founded by Francoise Barbira Freedman, Margaret Adey, Paul Rodgers and Jonathan Mark Treherne in May 2003 and is headquartered in Cambridge, the United Kingdom. | Fondateur | - |
CYP Design Ltd.
 CYP Design Ltd. BiotechnologyHealth Technology CYP Design Ltd. provides drug research and development services. It engages in the supporting drug research and development needs by offering stabilized, highly active cytochrome P450 (CYP) enzyme products. The firm also offers reliable contract research services in metabolism and toxicity testing and in bio catalysis. It has developed a generic expression system for the production of recombinant cytochrome P450 (CYP) in yeast, insect and mammalian cells. The company was founded by Bhabatosh Chaudhuri, Paul Barton Rodgers and William Primose in 2012 and is headquartered in Leicester, the United Kingdom. | Fondateur | - |
Psynova Neurotech Ltd.
 Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Président | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Psynova Neurotech Ltd.
Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Ampika Ltd.
Ampika Ltd. Drugstore ChainsRetail Trade Ampika Ltd. discovers and develops drugs. It develops consumer products and prescription drugs from plant-based compounds. Its products includes cardiovascular protection, anti-infectives, diabetes, oncology, dermatological conditions and neurological. The company was founded by Francoise Barbira Freedman, Margaret Adey, Paul Rodgers and Jonathan Mark Treherne in May 2003 and is headquartered in Cambridge, the United Kingdom. | Retail Trade |
CYP Design Ltd.
CYP Design Ltd. BiotechnologyHealth Technology CYP Design Ltd. provides drug research and development services. It engages in the supporting drug research and development needs by offering stabilized, highly active cytochrome P450 (CYP) enzyme products. The firm also offers reliable contract research services in metabolism and toxicity testing and in bio catalysis. It has developed a generic expression system for the production of recombinant cytochrome P450 (CYP) in yeast, insect and mammalian cells. The company was founded by Bhabatosh Chaudhuri, Paul Barton Rodgers and William Primose in 2012 and is headquartered in Leicester, the United Kingdom. | Health Technology |
Ithaka Life Sciences Ltd.
Ithaka Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services Ithaka Life Sciences Ltd. provides advisory, guidance, and support for the life science industry. The British company was founded by Paul Barton Rodgers, who has been the CEO since incorporation. | Commercial Services |
ProteinLogic Ltd.
ProteinLogic Ltd. Packaged SoftwareTechnology Services ProteinLogic Ltd. has developed a diagnostic technology platform called immiprint®, which detects non-obvious diagnostic patterns in soluble immune proteins in the blood and other body fluids through machine learning. ProteinLogic is based in Cambridge, UK. These patterns form unique signatures of disease presence, stage, and potential response to treatment. The immiprint® technology has been clinically validated with the development of a signature in blood for the ruling out of active tuberculosis (TB), meeting the stringent criteria of the WHO for such a diagnostic test. The British company expects to create considerable additional value through the validation of other immiprint® signatures in its early stage development pipeline, with a focus on infectious, autoimmune, and inflammatory diseases. | Technology Services |
Mironid Ltd.
Mironid Ltd. Pharmaceuticals: MajorHealth Technology Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom. | Health Technology |
